C07D 461/00
Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems
Official title: Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine (dimeric indolo alkaloids C07D519/04)
C07D461/00 (Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems) appears on 86 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 86
- Published applications
- 5
- Assignees
- 29
- Inventors
- 183
- Latest grant
- 28 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 9 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 1 | 0 |
| 1981 | 4 | 0 |
| 1982 | 8 | 0 |
| 1983 | 6 | 0 |
| 1984 | 11 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Analogs of vincamine and uses thereof28 Sep 2021US 11,130,764 B2University of Florida Research Foundation, Inc.
- Salts and crystal forms of diaza-benzofluoranthrene compounds21 Sep 2021US 11,124,506 B2Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory
- Diaza-benzofluoranthrene compounds10 Jul 2018US 10,017,507 B2Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory
- Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof8 Apr 2008US 7,354,918 B2Biocortech
- 20,21-dinor-eburnamenines18 Mar 2003US 6,534,515 B2Aventis Pharma S. A.
- Analogs of vincamine and uses thereof28 Nov 2019US 2019/0359622 A1University of Florida Research Foundation, Inc.
- Salts and crystal forms of diaza-benzofluoranthrene compounds6 Jun 2019US 2019/0169183 A1Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory
- Diaza-benzofluoranthrene compounds18 Jan 2018US 2018/0016270 A1Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory
- Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof19 Apr 2007US 2007/0088046 A1Biocortech
- Novel 20,21-dinor-eburnamenine18 Apr 2002US 2002/0045637 A1Aventis Pharma S. A.
Most cited
By later US patents
- Vincaminic acid esters26US 3,987,177 ASynthelabo · 1976
- Anti-depressive vincamine pyridoxal-5-phosphate26US 4,137,316 ASociete d'Etudes de Produits Chimiques · 1979
- Alkaloid esters19US 4,035,370 ARichter Gedeon Vegyeszeti Gyar Rt. · 1977
- Increasing vigilance or treating cerebral insufficiency with substituted vincamines17US 4,146,643 ASandoz Ltd. · 1979
- Citric acid salt of (+) vinpocetine12US 4,749,707 ACovex, S.A. · 1988